Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP921449.RAVU-svAo5U5cCn3AGVuVHuBpeOffZ4YiwGBnP1dpwW4A130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921449.RAVU-svAo5U5cCn3AGVuVHuBpeOffZ4YiwGBnP1dpwW4A130_provenance.
• NP531401.RAUWPI84Qf9P7IUXGYteExwKJYQx22cPsYly9rLkwAguM130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP531401.RAUWPI84Qf9P7IUXGYteExwKJYQx22cPsYly9rLkwAguM130_provenance.
• NP794095.RARHfzOtfnjT0TFnX4rsV2h2-HGjY5zP5OrNPISBQ2LIo130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP794095.RARHfzOtfnjT0TFnX4rsV2h2-HGjY5zP5OrNPISBQ2LIo130_provenance.
• assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP733009.RAmArhOImckrY01pxPAPEnbMyhiBnX2l2LJorALCU58hs130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP733009.RAmArhOImckrY01pxPAPEnbMyhiBnX2l2LJorALCU58hs130_provenance.
• NP630116.RAYfWRtTDmc5_wzyQvuI0H31XCjWvxq7rxbbZWKf094Fo130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630116.RAYfWRtTDmc5_wzyQvuI0H31XCjWvxq7rxbbZWKf094Fo130_provenance.
• NP630118.RAakBiHy2WT7YzI8jWUgCmwpwO94qqNL9bFN0fibJAj0w130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630118.RAakBiHy2WT7YzI8jWUgCmwpwO94qqNL9bFN0fibJAj0w130_provenance.
• NP221195.RAor0yb2E2PeftMwkcF-7UoqpWFdb7y6oIHMbUbL9Qa_I130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP221195.RAor0yb2E2PeftMwkcF-7UoqpWFdb7y6oIHMbUbL9Qa_I130_provenance.
• NP992203.RAjYD75gfuvgKq5Mn1A-u2s-b8_HdFPKwwgSrWonN2gb8130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP992203.RAjYD75gfuvgKq5Mn1A-u2s-b8_HdFPKwwgSrWonN2gb8130_provenance.
• NP900853.RAi97gj9pvfie2hBycAEFTM5_AN4wKRovnpN5hqVFXYZw130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP900853.RAi97gj9pvfie2hBycAEFTM5_AN4wKRovnpN5hqVFXYZw130_provenance.
• NP630120.RAt7p9CyC48yJ7r_uh-z8JXAXIPhVzqVyXX-2qPodT0z8130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630120.RAt7p9CyC48yJ7r_uh-z8JXAXIPhVzqVyXX-2qPodT0z8130_provenance.
• NP630122.RAhRK1pSNPwjG1RJcEc0OTltJlR49pKoMlyI3nXBJEVPM130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630122.RAhRK1pSNPwjG1RJcEc0OTltJlR49pKoMlyI3nXBJEVPM130_provenance.
• NP309889.RAKkU6ZnmiiQp81tQYtrLlz4UBZpUNBX4kKVTeFGhGM5g130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309889.RAKkU6ZnmiiQp81tQYtrLlz4UBZpUNBX4kKVTeFGhGM5g130_provenance.
• NP786365.RALh9l-L5mYRniluN64zYCRUjUNiLyJTnJq61juxgbGc0130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786365.RALh9l-L5mYRniluN64zYCRUjUNiLyJTnJq61juxgbGc0130_provenance.
• NP630119.RAJtcC8S4yRa2z2_6KzJlBrGtTXhzhQr-5ZDRJuWA_-ZE130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630119.RAJtcC8S4yRa2z2_6KzJlBrGtTXhzhQr-5ZDRJuWA_-ZE130_provenance.
• NP630121.RAIOCa4uoDsZUNFhsuG1sf_jyorWFPOdAZm75uClcwOCY130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630121.RAIOCa4uoDsZUNFhsuG1sf_jyorWFPOdAZm75uClcwOCY130_provenance.
• NP630115.RA9RT3Oh5Vu3-qhC2T0Cz6HHC5wPPbHl7rbcnAJ3nJ2sA130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630115.RA9RT3Oh5Vu3-qhC2T0Cz6HHC5wPPbHl7rbcnAJ3nJ2sA130_provenance.
• NP630123.RA0_unQV0we9GcJlIMqt8qgwvvA_vW9zbBoCDP5Jlh1tk130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630123.RA0_unQV0we9GcJlIMqt8qgwvvA_vW9zbBoCDP5Jlh1tk130_provenance.
• NP630124.RA4EJ3515a66tUE0_Ky5NOGCOkgXXY64guPpA4dd_lKD0130_assertion description "[The data suggest that lysosomal dysfunction and accumulation of storage material require increased biogenesis of LAP/ACP2 and LAMP-2 positive membranes which makes LAP/ACP2 suitable as biomarker of Batten disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP630124.RA4EJ3515a66tUE0_Ky5NOGCOkgXXY64guPpA4dd_lKD0130_provenance.